Cambio high quality human placental genomic intact DNA
DNA derived from placentae is composed of that from the foetal cells and also a small number of maternal cells. The maternal cells fall away with the placenta when the placenta is delivered following birth. Human placental genomic DNA is uniquely suited to many different uses in molecular biology. It can be used in applications where nucleic acid blocking is required such as Southern hybridisation, specialised cytogenetic assays, fluorescence in situ hybridisation (FISH), Northern hybridisation etc.
Cambio’s human placental genomic DNA is total genomic DNA and will specifically block human random repeat sequences making it an ideal blocker for hybridisation experiments.
Our DNA is supplied as convenient small pack sizes (milligrams) but we also supply in bulk (gram quantities) as required.
Blocking agent for a wide range of different DNA- or RNA-based applications, including but not limited to:
- Southern hybridization
- Northern hybridization
- Applications employing nucleic acid probes
- Nucleic acid binding assays
- Fluorescence in-situ Hybiridsation (FISH)
- Cytogenetic assays
- PCR standards
- As internal Controls
Cambio’s intact human placental DNA (male or female) is isolated from fresh donor placentae by phenol extraction. The DNA is of high molecular weight and high purity. Our Sonicated DNA contains DNA fragments of consistent size. Tests have shown minimal nuclease degradation.
Contact us for bulk discounts, and custom-dispense
The placentae used for obtaining the DNA have tested negative for the following:
Hepatitis (Hep-B & Hep C)
Human ImmunoDeficiency Virus (HIV-1 and HIV-2)
Human T-cell Lymphotropic Virus ( HTLV-1 & HTLV-2)
If you cannot find the answer to your problem below then please
contact us or telephone 01954 210 200